Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Nov 2025 is 1.88% vs -0.22% in Nov 2024
Consolidate Net Profit
YoY Growth in quarter ended Nov 2025 is 125.73% vs -71.00% in Nov 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Nov 2025 is 1.90% vs -18.89% in Nov 2024
Interest
YoY Growth in quarter ended Nov 2025 is -2.94% vs 466.67% in Nov 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Nov 2025 has fallen from Nov 2024
Compare Quarterly Results Of Daito Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Nov 2025 is -6.77% vs -7.29% in Aug 2025
YoY Growth in quarter ended Nov 2025 is 1.88% vs -0.22% in Nov 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Nov 2025 is -19.53% vs 0.15% in Aug 2025
YoY Growth in quarter ended Nov 2025 is 125.73% vs -71.00% in Nov 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Nov 2025 is -16.01% vs 8.85% in Aug 2025
YoY Growth in quarter ended Nov 2025 is 1.90% vs -18.89% in Nov 2024
Quarterly - Interest
QoQ Growth in quarter ended Nov 2025 is 10.00% vs -21.05% in Aug 2025
YoY Growth in quarter ended Nov 2025 is -2.94% vs 466.67% in Nov 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Nov 2025 has fallen from Aug 2025
YoY Growth in quarter ended Nov 2025 has fallen from Nov 2024






